NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.
The post NHS rolling out first targeted brain tumour treatment for children and young people appeared first on Cancer Research UK - Cancer News.